Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015Lioness Magazine Interview | Interview | Mar 11, 2021HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Lioness MagazinePharmaBoardRoom Article | Article | Mar 8, 2021HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by PharmaBoardRoom and Genialis PodcastOct 27, 2020HiFiBiO Therapeutics CEO Liang Schweizer Named one of the World’s Top Female FoundersOct 26, 2020HiFiBiO Therapeutics Completes First Cohort of a Phase I Study of its SARS-CoV-2 Neutralizing Antibody for the Treatment and Prevention of COVID-19Sep 24, 2020HiFiBiO Therapeutics CEO Liang Schweizer Receives 2020 Extraordinary Women Advancing Healthcare Award< 1 … 8 9 10 11 12 … 17 >
